| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $558,663 ) |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 001 | 2 | 4/16/2024 | NON-COMPETING CONTINUATION | $29,404 |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 2 | 12/15/2023 | NON-COMPETING CONTINUATION | $529,259 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $588,065 ) |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Biology Research | 000 | 1 | 12/16/2022 | NEW | $588,065 |
|
|